Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours Β· Estimated delivery Aug 19 - Aug 24
Starting January 1, 2026, these medications will no longer be covered for weight loss or weight loss-related indications: Ozempic Rybelsus Mounjaro Victoza Byeta Bydureon Trulicity Ensuring Continuation of Therapy If you are currently prescribed any GLP-1 medication for an approved indication, it is important to ensure your prescriber includes the appropriate diagnosis code (ICD-10) when submitting your prescription
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has gained significant attention in recent years for its role in aiding weight loss and managing type 2 diabetes
We understand that your health journey requires more than just a prescription
Prior to this, actual dulaglutide prescriptions had comparatively increased overall by 36% during the 13-month period between January 2021 and January 2022
US$ 23.46
US$ 20.75
US$ 29.82
US$ 27.82
US$ 23.24
US$ 29.89
US$ 20.99
US$ 22.93
